Tirzepatide, having received FDA approval, has a more defined safety record, though patients should be monitored for potential risks such as pancreatitis or thyroid tumors, which have been concerns with GLP-1 receptor agonists in general
Future Horizons Taken together, these trials show that 2025 was not defined by marginal gains or isolated wins
Additionally, to address concerns about program gaming, agencies will now implement annual application limits per firm to ensure a broader distribution of awards among smaller, emerging businesses
While this is a real concern for the patient, the GPs decision is based on the established clinical effectiveness of the injection schedule
Some clients experience mild, temporary soreness at the injection site
WITHDRAWAL TIME: 0 day